Clinical Approach to Dyspnea
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of dyspnea
Dyspnea is one of the most common and distressing symptoms encountered in clinical medicine, accounting for approximately 3 to 4 million emergency department visits annually in the United States alone. It is the primary complaint in roughly 25% of ambulatory care visits and affects up to 50% of patients admitted to acute care hospitals. Chronic dyspnea impacts an estimated 9 to 13% of the general adult population, with prevalence increasing significantly with age—affecting nearly 30% of individuals over 65 years. The symptom carries substantial prognostic importance: the presence of dyspnea is an independent predictor of mortality in patients with cardiac and pulmonary disease, often outweighing objective measures such as ejection fraction or forced expiratory volume.
Definition
Dyspnea is defined as the subjective experience of breathing discomfort consisting of qualitatively distinct sensations that vary in intensity. It is a symptom, not a sign—meaning it cannot be directly observed or measured by the clinician and must be reported by the patient. The experience arises from complex interactions among multiple physiological, psychological, social, and environmental factors and may induce secondary physiological and behavioral responses. The American Thoracic Society emphasizes that dyspnea, like pain, involves both the perception of a sensation and the reaction to that perception.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Minutes to hours | Pulmonary embolism, pneumothorax, acute coronary syndrome, asthma exacerbation, anaphylaxis, foreign body aspiration | Often represents life-threatening conditions requiring immediate evaluation and intervention; high index of suspicion for emergencies |
| Subacute | Days to weeks | Pneumonia, pleural effusion, heart failure exacerbation, anemia, lung malignancy | Suggests progressive or evolving pathology; opportunity for diagnosis before critical deterioration |
| Chronic | Greater than 4 to 8 weeks | Chronic obstructive pulmonary disease, heart failure, interstitial lung disease, obesity, deconditioning, pulmonary hypertension | Often multifactorial; significant impact on quality of life; requires systematic workup to identify all contributing factors |
Classification by Qualitative Character
Patients describe dyspnea using distinct qualitative descriptors that correlate with underlying pathophysiology. Understanding these descriptors helps narrow the differential diagnosis.
Air Hunger (Unsatisfied Inspiration)
The sensation of an uncomfortable urge to breathe, similar to the feeling experienced during breath-holding. This descriptor is associated with increased respiratory drive from hypercapnia, hypoxemia, or metabolic acidosis. Commonly reported in conditions such as heart failure, pulmonary embolism, and metabolic acidosis.
Increased Work or Effort of Breathing
The sensation that breathing requires excessive muscular effort. Associated with conditions that increase the mechanical load on the respiratory system, such as airway obstruction in chronic obstructive pulmonary disease and asthma, or decreased compliance in pulmonary fibrosis and pleural effusion.
Chest Tightness or Constriction
A sensation of the chest being squeezed or constricted. Particularly characteristic of bronchoconstriction in asthma and may also occur with acute coronary syndrome. This descriptor has reasonable specificity for airway disease when present.
Rapid or Shallow Breathing
Awareness of an increased respiratory rate or inability to take deep breaths. Often associated with restrictive lung diseases, anxiety-related hyperventilation, and conditions causing chest wall pain that limits inspiratory depth.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Exertional | Dyspnea that occurs or worsens with physical activity | Cardiac disease, pulmonary disease, anemia, deconditioning—the most common pattern; severity graded by activity threshold |
| Orthopnea | Dyspnea occurring when supine, relieved by sitting upright; quantified by number of pillows needed | Heart failure (increased venous return in supine position), severe chronic obstructive pulmonary disease, bilateral diaphragm weakness |
| Paroxysmal Nocturnal Dyspnea | Episodes of severe dyspnea awakening patient from sleep, typically 1 to 3 hours after falling asleep | Highly suggestive of heart failure; caused by fluid redistribution during recumbency |
| Platypnea | Dyspnea occurring in the upright position, relieved by lying down | Hepatopulmonary syndrome, intracardiac shunts (patent foramen ovale with orthodeoxia), post-pneumonectomy syndrome |
| Trepopnea | Dyspnea occurring in one lateral decubitus position but not the other | Unilateral lung disease, large pleural effusion, cardiac disease affecting one side preferentially |
| Episodic or Paroxysmal | Intermittent attacks of dyspnea with symptom-free intervals | Asthma, panic disorder, cardiac arrhythmias, recurrent pulmonary emboli |
| At Rest | Dyspnea present without exertion | Severe or advanced disease; may indicate respiratory failure, severe heart failure, or psychogenic dyspnea |
Severity Grading: The Modified Medical Research Council Dyspnea Scale
| Grade | Description | Functional Impact |
|---|---|---|
| 0 | Dyspnea only with strenuous exercise | No limitation of daily activities |
| 1 | Short of breath when hurrying on level ground or walking up a slight hill | Mild limitation; able to keep pace with peers on flat ground |
| 2 | Walks slower than contemporaries on level ground due to breathlessness, or has to stop for breath when walking at own pace | Moderate limitation; noticeable impact on walking ability |
| 3 | Stops for breath after walking approximately 100 meters or after a few minutes on level ground | Severe limitation; significantly restricted mobility |
| 4 | Too breathless to leave the house, or breathless when dressing or undressing | Very severe limitation; essentially housebound |
Key Concept: The “Big Four” Causes of Chronic Dyspnea
In patients with chronic dyspnea and an unremarkable initial evaluation, four conditions account for approximately 85% of cases:
- Asthma — including cough-variant and exercise-induced forms
- Chronic obstructive pulmonary disease — even in non-smokers or minimal smokers
- Heart failure — including heart failure with preserved ejection fraction
- Interstitial lung disease — often presents with exertional dyspnea before radiographic changes
Additionally, obesity, deconditioning, and anxiety disorders are frequently contributing or primary factors that should always be considered.
Impact on Quality of Life
Beyond Physical Limitation
Dyspnea profoundly impacts quality of life across multiple domains. Patients experience physical limitations that restrict mobility and independence, psychological distress including anxiety and depression, social isolation due to inability to participate in activities, and sleep disturbance. The fear of dyspnea itself often leads to avoidance behaviors that further compound deconditioning. Studies consistently show that dyspnea severity correlates more strongly with quality of life measures than objective parameters such as pulmonary function tests or imaging findings.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of dyspnea
Dyspnea is a complex sensation arising from multiple interacting physiological systems. Unlike many symptoms with straightforward mechanisms, dyspnea results from the integration of signals from chemoreceptors, mechanoreceptors, and higher cortical centers. Understanding these mechanisms is essential for identifying the underlying cause and selecting appropriate therapy. The sensation occurs when there is a mismatch between the neural respiratory drive (the brain’s command to breathe) and the mechanical response of the respiratory system (the actual ventilation achieved).
The Efferent-Afferent Mismatch Model
Core Concept: Dyspnea fundamentally arises from a mismatch between the central respiratory motor command (efferent signal) and the incoming feedback from the respiratory system (afferent signal). When the brain sends a command to breathe, it simultaneously generates an “expectation” of what the resulting ventilation should feel like. If the afferent feedback does not match this expectation—because of mechanical limitation, weakness, or abnormal chemoreceptor input—dyspnea results.
| Component | Structure | Function |
|---|---|---|
| Central Respiratory Controller | Medullary respiratory centers (dorsal and ventral respiratory groups), pontine pneumotaxic center | Generates the basic respiratory rhythm and integrates inputs from chemoreceptors and higher centers to modulate ventilation |
| Efferent Pathway | Phrenic nerves (C3-C5), intercostal nerves (T1-T12), accessory nerve (CN XI) | Transmits motor commands to respiratory muscles; corollary discharge sent to sensory cortex creates the sense of respiratory effort |
| Respiratory Muscles | Diaphragm (primary), external intercostals, accessory muscles (sternocleidomastoid, scalenes) | Generate negative intrathoracic pressure for inspiration; dysfunction increases effort and triggers dyspnea |
| Afferent Pathways | Vagus nerve (CN X), phrenic nerve afferents, spinal afferents | Transmit sensory information from lungs, airways, chest wall, and respiratory muscles back to the brainstem and cortex |
| Cortical Processing | Insular cortex, anterior cingulate cortex, amygdala | Conscious perception of dyspnea, emotional response (anxiety, fear), and behavioral adaptation |
Receptor Types and Clinical Relevance
Chemoreceptors
Location: Central chemoreceptors in the medulla (respond to pH and carbon dioxide); peripheral chemoreceptors in carotid and aortic bodies (respond primarily to oxygen, also to carbon dioxide and pH)
Stimuli: Hypercapnia, hypoxemia, acidosis
Clinical relevance: Drive the sensation of “air hunger” or unsatisfied inspiration; explain dyspnea in metabolic acidosis (even with normal oxygen levels), hypoxemia, and hypercapnic respiratory failure
Pulmonary Mechanoreceptors
Location: Slowly adapting stretch receptors in airway smooth muscle; rapidly adapting receptors (irritant receptors) in airway epithelium; C-fiber receptors (J receptors) in lung parenchyma and bronchial walls
Stimuli: Lung inflation, airway irritation, pulmonary congestion, inflammatory mediators
Clinical relevance: Mediate bronchospasm-related dyspnea, dyspnea from pulmonary edema and interstitial disease, and the “tight chest” sensation in asthma
Chest Wall and Muscle Receptors
Location: Muscle spindles in intercostal muscles, Golgi tendon organs in the diaphragm, joint receptors in the thoracic cage
Stimuli: Muscle tension, length changes, joint position
Clinical relevance: Sense increased work of breathing; explain dyspnea in chest wall restriction (kyphoscoliosis), respiratory muscle weakness (neuromuscular disease), and hyperinflation (chronic obstructive pulmonary disease)
How Conditions Cause Dyspnea
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Chronic Obstructive Pulmonary Disease | Dynamic hyperinflation during exertion causes mechanical disadvantage of inspiratory muscles and increased elastic work of breathing; airflow limitation increases resistive work; V/Q mismatch may cause hypoxemia | Bronchodilators reduce hyperinflation; pulmonary rehabilitation improves efficiency; supplemental oxygen if hypoxemic |
| Asthma | Bronchoconstriction stimulates airway irritant receptors, causing chest tightness; increased airway resistance raises work of breathing; hyperinflation in severe attacks | Bronchodilators and anti-inflammatory agents relieve obstruction; rapid onset of relief correlates with symptom improvement |
| Heart Failure | Pulmonary congestion stimulates J receptors; reduced cardiac output causes lactic acidosis with exertion, stimulating chemoreceptors; respiratory muscle underperfusion impairs their function | Diuretics reduce congestion; vasodilators and inotropes improve cardiac output; treating the underlying cause addresses multiple mechanisms |
| Interstitial Lung Disease | Decreased lung compliance increases elastic work of breathing; V/Q mismatch and diffusion limitation cause hypoxemia, especially with exertion; stimulation of parenchymal C-fibers | Supplemental oxygen addresses hypoxemia; anti-fibrotic or immunosuppressive therapy may slow progression; pulmonary rehabilitation improves efficiency |
| Pulmonary Embolism | V/Q mismatch causes hypoxemia; dead space ventilation increases minute ventilation requirement; release of inflammatory mediators stimulates pulmonary receptors; right heart strain may reduce cardiac output | Anticoagulation prevents clot extension; thrombolysis or embolectomy in massive embolism; supplemental oxygen as needed |
| Anemia | Reduced oxygen-carrying capacity requires increased cardiac output and minute ventilation during exertion; tissue hypoxia may trigger chemoreceptor stimulation at lower levels of exertion | Blood transfusion for severe or symptomatic anemia; treatment of underlying cause; iron supplementation if iron deficient |
| Obesity | Increased mechanical load on respiratory system; reduced chest wall compliance; increased oxygen consumption for any given level of activity; possible sleep-disordered breathing affecting respiratory drive | Weight loss is primary intervention; treatment of obstructive sleep apnea; exercise programs adapted to ability level |
| Anxiety and Panic Disorder | Central amplification of dyspnea perception; hyperventilation causes hypocapnia with paradoxical symptoms; heightened awareness of normal respiratory sensations | Cognitive behavioral therapy; anxiolytics when appropriate; breathing retraining; ruling out organic causes remains essential |
| Neuromuscular Disease | Respiratory muscle weakness creates mismatch between central drive and achieved ventilation; eventual hypercapnic respiratory failure as muscles fatigue | Non-invasive ventilation for respiratory support; treatment of underlying condition when possible; careful monitoring of respiratory function |
Three Qualitative Dimensions of Dyspnea
Understanding Dyspnea Quality Helps Identify Mechanism
Research has identified three primary qualitative dimensions of dyspnea, each associated with distinct physiological mechanisms:
- Air hunger (unsatisfied inspiration): Arises primarily from chemoreceptor stimulation—elevated carbon dioxide, decreased oxygen, or acidosis increases respiratory drive without proportional increase in ventilation. This is the most distressing form of dyspnea.
- Work or effort: Arises from increased motor command to respiratory muscles, typically due to mechanical loading (obstruction, restriction, or muscle weakness). The corollary discharge accompanying motor output creates the sense of effort.
- Chest tightness: Appears to arise from stimulation of pulmonary receptors, particularly during bronchoconstriction. This sensation has reasonable specificity for asthma when present.
Individual patients may experience one or more of these dimensions, and the predominant quality can shift as disease state changes.
Often Overlooked Mechanism: Deconditioning
Deconditioning is frequently underappreciated as a cause of dyspnea. When patients become less active—due to illness, hospitalization, or lifestyle—multiple physiological changes occur: decreased mitochondrial density in skeletal muscles reduces oxygen extraction efficiency, cardiac output reserve diminishes, and ventilatory efficiency worsens. The result is earlier onset of lactic acidosis during exertion, which stimulates chemoreceptors and increases ventilatory demand. This creates a vicious cycle: dyspnea leads to activity avoidance, which worsens deconditioning, which worsens dyspnea. Deconditioning can be the primary cause of dyspnea or can significantly amplify dyspnea from other conditions. Pulmonary rehabilitation addresses this mechanism regardless of the underlying disease.
Pathophysiology of Positional Dyspnea Patterns
| Pattern | Physiological Mechanism | Associated Conditions |
|---|---|---|
| Orthopnea | Supine position increases venous return, raising pulmonary capillary pressure and causing or worsening pulmonary congestion; abdominal contents compress diaphragm, reducing functional residual capacity | Heart failure, severe chronic obstructive pulmonary disease, bilateral diaphragm paralysis, massive ascites |
| Paroxysmal Nocturnal Dyspnea | Gradual reabsorption of peripheral edema during recumbency increases intravascular volume over hours; nocturnal decrease in sympathetic tone reduces cardiac function; hypoxemia may occur during sleep | Heart failure (very specific when present), severe chronic obstructive pulmonary disease, obstructive sleep apnea |
| Platypnea-Orthodeoxia | Upright position increases shunting through defect (intracardiac or intrapulmonary) due to gravitational effects on blood flow or change in geometry of the defect | Patent foramen ovale with right-to-left shunting, hepatopulmonary syndrome, pulmonary arteriovenous malformations, post-pneumonectomy syndrome |
3. History Taking
A comprehensive approach to eliciting the dyspnea history
Red Flags — Require Urgent Evaluation
- Sudden onset at rest — Pulmonary embolism, pneumothorax, acute coronary syndrome
- Stridor or inability to speak — Upper airway obstruction, anaphylaxis
- Chest pain with dyspnea — Acute coronary syndrome, pulmonary embolism, aortic dissection
- Hemoptysis — Pulmonary embolism, lung malignancy, infection
- Syncope or presyncope — Massive pulmonary embolism, cardiac arrhythmia, severe aortic stenosis
- Altered mental status or confusion — Hypoxemia, hypercapnia, cardiogenic shock
- Cyanosis — Severe hypoxemia requiring immediate intervention
- Unilateral leg swelling — Deep vein thrombosis with possible pulmonary embolism
- Recent surgery or immobilization — High risk for venous thromboembolism
- Known severe cardiac or pulmonary disease with acute worsening — Decompensation requiring urgent management
Systematic History: The “BREATHE” Approach
Use the mnemonic “BREATHE” to ensure comprehensive history taking for dyspnea:
- B — Begin with onset and duration: When did it start? Sudden (seconds to minutes) versus gradual (hours to days)? Acute, subacute, or chronic? What were you doing when it started?
- R — Related symptoms and Red flags: Chest pain? Cough? Fever? Hemoptysis? Leg swelling? Palpitations? Weight change? Ask specifically about red flag symptoms.
- E — Exertion and Exacerbating factors: What level of activity triggers dyspnea? Has your exercise tolerance changed? What makes it worse? Cold air, allergens, lying flat, eating?
- A — Alleviating factors and Associated patterns: What makes it better? Rest? Sitting upright? Inhalers? Is there orthopnea (how many pillows)? Paroxysmal nocturnal dyspnea? Episodic versus continuous?
- T — Timeline and Trajectory: Is it getting worse, better, or stable? Constant or intermittent? Progressive decline or fluctuating course? Previous similar episodes?
- H — History (past medical, medications, social): Known cardiac or lung disease? Prior venous thromboembolism? Current medications including over-the-counter? Smoking history? Occupational exposures? Recent travel or immobilization?
- E — Effect on daily life: Impact on work, sleep, activities? Quantify with Modified Medical Research Council scale. Screen for anxiety and depression which frequently coexist.
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Heart Failure | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, weight gain | “Do you need to prop yourself up on pillows to sleep? Do you ever wake up at night gasping for air? Have you noticed swelling in your legs or sudden weight gain?” |
| Chronic Obstructive Pulmonary Disease | Smoking history, chronic productive cough, progressive exertional dyspnea | “How many years have you smoked and how many cigarettes per day? Do you have a daily cough with phlegm? Has your breathing been getting slowly worse over months to years?” |
| Asthma | Episodic symptoms, triggers, nocturnal symptoms, atopy, wheeze | “Does your breathing come and go, with periods when you feel completely normal? Does cold air, exercise, or allergies trigger your symptoms? Is it worse at night or early morning?” |
| Pulmonary Embolism | Sudden onset, pleuritic chest pain, risk factors, unilateral leg symptoms | “Did this come on suddenly? Do you have pain when you take a deep breath? Have you had recent surgery, long travel, or been immobilized? Is one leg swollen, red, or painful?” |
| Pneumonia | Fever, productive cough, pleuritic pain, acute onset | “Do you have a fever or chills? Are you coughing up colored sputum? Did this develop over a few days along with feeling unwell?” |
| Interstitial Lung Disease | Progressive exertional dyspnea, dry cough, exposures, connective tissue disease | “Has your breathing been getting gradually worse over months? Do you have a dry, hacking cough? Have you been exposed to birds, mold, or certain dusts? Do you have joint pain or skin changes?” |
| Anemia | Fatigue, pallor, palpitations, bleeding history, dietary factors | “Do you feel unusually tired? Have you noticed you look pale? Do you get palpitations with exertion? Have you had any bleeding or are your periods heavy? How is your diet?” |
| Anxiety or Panic Disorder | Episodic, associated panic symptoms, sighing, perioral tingling | “Does the breathlessness come in episodes with intense fear or panic? Do you get tingling around your mouth or in your fingers? Do you find yourself sighing or yawning frequently?” |
| Pleural Effusion | Pleuritic pain preceding dyspnea, positional component, reduced breath sounds | “Did you have sharp chest pain that has now become more of a dull ache with breathlessness? Is it more comfortable lying on one particular side?” |
| Obesity and Deconditioning | Weight gain, reduced activity level, symptoms only with exertion | “Has your weight changed recently? Have you become less active over time? Are you completely comfortable at rest and only short of breath with activity?” |
Characterizing the Quality of Dyspnea
Ask About the Sensation Itself
Patients describe dyspnea in different ways, and these descriptors correlate with underlying mechanisms:
- “I can’t get enough air” or “I feel like I’m suffocating” — Air hunger; suggests chemoreceptor stimulation (hypoxemia, hypercapnia, acidosis)
- “Breathing is hard work” or “My breathing is heavy” — Increased effort; suggests mechanical loading (obstruction, restriction)
- “My chest feels tight” — Chest tightness; relatively specific for bronchoconstriction (asthma)
- “I can’t take a deep breath” — May indicate chest wall pain, pleural disease, or restrictive lung disease
- “I’m breathing too fast and can’t slow down” — May suggest anxiety, hyperventilation, or metabolic acidosis
Medication and Substance History
Medications That Can Cause or Worsen Dyspnea
- Beta-blockers — May unmask or worsen asthma; can cause fatigue mimicking dyspnea; may worsen heart failure acutely
- Non-steroidal anti-inflammatory drugs — Fluid retention worsening heart failure; aspirin-exacerbated respiratory disease
- Amiodarone — Pulmonary toxicity causing interstitial lung disease (may occur years after starting)
- Methotrexate — Pneumonitis (acute or subacute onset)
- Nitrofurantoin — Acute or chronic pulmonary toxicity
- Bleomycin and other chemotherapeutics — Pulmonary fibrosis
- Illicit drugs — Cocaine (pulmonary edema, hemorrhage), opioids (respiratory depression), inhaled substances
Medications Suggesting Underlying Disease
- Diuretics — Suggests known heart failure or hypertension
- Inhalers — Suggests known airway disease; ask about frequency of rescue inhaler use
- Anticoagulants — May indicate prior venous thromboembolism or atrial fibrillation
- Immunosuppressants — Risk of opportunistic infections; may indicate connective tissue disease
- Oral contraceptives or hormone replacement therapy — Risk factor for venous thromboembolism
Adherence and Inhaler Technique
For patients with known respiratory disease, poor adherence or incorrect inhaler technique is a common cause of suboptimal control and persistent symptoms.
Social, Occupational, and Environmental History
| Factor | What to Ask | Clinical Relevance |
|---|---|---|
| Smoking | Current, former, or never? Pack-years (packs per day × years smoked)? Age started and stopped? Exposure to secondhand smoke? | Chronic obstructive pulmonary disease, lung cancer, cardiovascular disease; pack-years quantifies cumulative exposure |
| Vaping and E-cigarettes | Current use? What substances? Duration and frequency? | E-cigarette or vaping product use-associated lung injury (EVALI); may cause acute respiratory failure |
| Occupational Exposures | Current and past occupations? Exposure to dusts, fumes, chemicals, asbestos? Use of respiratory protection? | Occupational asthma, pneumoconioses (silicosis, asbestosis), hypersensitivity pneumonitis, mesothelioma |
| Environmental Exposures | Pets (especially birds)? Mold or water damage in home? Hot tubs? Humidifiers? Feather bedding? | Hypersensitivity pneumonitis from organic antigens (bird fancier’s lung, hot tub lung) |
| Travel and Immobilization | Recent long-haul travel? Prolonged bed rest or immobilization? Recent hospitalization or surgery? | Risk factors for venous thromboembolism and pulmonary embolism |
| Living Situation | Home heating source? Indoor air quality? Biomass fuel exposure? Crowded living conditions? | Biomass smoke exposure is a major cause of chronic obstructive pulmonary disease globally; crowding increases infection risk |
Family History
Pulmonary Conditions
- Alpha-1 antitrypsin deficiency (early-onset emphysema)
- Asthma and atopic diseases
- Pulmonary fibrosis (familial forms exist)
- Cystic fibrosis
- Primary ciliary dyskinesia
Cardiac and Other Conditions
- Premature coronary artery disease
- Cardiomyopathy
- Sudden cardiac death
- Venous thromboembolism (inherited thrombophilias)
- Connective tissue diseases
4. Physical Examination
A systematic head-to-toe approach for dyspnea
Systematic Framework: Use the “General → Vital Signs → Head-to-Toe” approach for complete examination of patients presenting with dyspnea. The examination should be guided by the history but comprehensive enough to detect unexpected findings. Remember that cardiopulmonary examination is central, but extra-pulmonary findings often provide crucial diagnostic clues.
General Inspection
Begin by observing the patient before touching them. Much can be learned in the first few seconds.
- Level of distress: Comfortable at rest versus visibly dyspneic? Able to speak in full sentences, phrases, or only single words? Tripod positioning (sitting upright, leaning forward, hands on knees)?
- Respiratory pattern: Respiratory rate? Use of accessory muscles (sternocleidomastoid, scalene muscles)? Intercostal or supraclavicular retractions? Paradoxical abdominal movement (inward during inspiration suggesting diaphragm weakness)?
- Color: Cyanosis (central involving lips and tongue versus peripheral involving fingers)? Pallor suggesting anemia? Plethora suggesting polycythemia?
- Body habitus: Obesity? Cachexia (suggesting malignancy or severe chronic obstructive pulmonary disease)? Barrel chest (hyperinflation)?
- Audible breathing: Stridor (inspiratory suggests upper airway obstruction)? Audible wheeze? Grunting?
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute); bradypnea (less than 12, concerning for fatigue or central depression) | Tachypnea is sensitive but nonspecific; may be the earliest sign of respiratory distress; rate greater than 30 indicates severe distress |
| Oxygen Saturation | Hypoxemia (less than 94% on room air); note if on supplemental oxygen; check for proper probe placement | Saturation less than 90% is concerning; note that normal saturation does not exclude serious disease (pulmonary embolism may have normal saturation); carbon monoxide poisoning gives falsely normal readings |
| Heart Rate | Tachycardia (greater than 100 beats per minute); bradycardia; irregularity | Tachycardia may indicate hypoxemia, pain, anxiety, anemia, or arrhythmia; new atrial fibrillation may cause dyspnea; bradycardia with dyspnea suggests severe hypoxemia or conduction disease |
| Blood Pressure | Hypotension (concerning for shock); severe hypertension; pulsus paradoxus (greater than 10 mmHg drop with inspiration) | Hypotension with dyspnea suggests massive pulmonary embolism, tension pneumothorax, or cardiogenic shock; pulsus paradoxus suggests tamponade or severe asthma |
| Temperature | Fever; hypothermia in severe infection | Fever suggests infection (pneumonia, sepsis); may also occur with pulmonary embolism; hypothermia in elderly may indicate severe infection |
Head and Neck Examination
Head, Eyes, Ears, Nose, and Throat
- Conjunctivae: Pallor (anemia)? Injection (allergic disease)?
- Nasal mucosa: Pale, boggy turbinates (allergic rhinitis)? Polyps? Deviated septum?
- Oropharynx: Tonsillar enlargement? Uvular deviation? Signs of angioedema?
- Voice: Hoarseness (recurrent laryngeal nerve involvement, vocal cord dysfunction)?
Neck
- Jugular venous pressure: Elevated (greater than 4 cm above sternal angle) suggests right heart failure, volume overload, pulmonary hypertension, tamponade
- Hepatojugular reflux: Sustained elevation with abdominal pressure suggests heart failure
- Trachea: Deviation (pneumothorax, large effusion, mass)?
- Thyroid: Goiter (may cause tracheal compression)?
- Lymphadenopathy: Malignancy, infection, sarcoidosis
Respiratory Examination
Inspection
- Chest shape: Barrel chest (hyperinflation in chronic obstructive pulmonary disease), kyphoscoliosis (restrictive defect), pectus deformities
- Chest wall movement: Symmetry of expansion (reduced on side of effusion, pneumothorax, or collapse)? Accessory muscle use?
- Scars: Previous thoracotomy, sternotomy, chest tube sites
Palpation
- Chest expansion: Place hands on lower ribs with thumbs at midline; reduced expansion is less than 5 cm total or asymmetric
- Tactile fremitus: Increased over consolidation; decreased over effusion or pneumothorax
- Tracheal position: Deviation away from tension pneumothorax or large effusion; toward collapse or fibrosis
- Subcutaneous emphysema: Crepitus indicating air in soft tissues (pneumothorax, ruptured airway)
Percussion
- Resonance: Normal percussion note; hyperresonant (pneumothorax, severe hyperinflation); dull (consolidation, effusion, mass)
- Diaphragm excursion: Reduced in hyperinflation or diaphragm dysfunction
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Vesicular breath sounds | Normal; soft, low-pitched, heard throughout inspiration and early expiration | Normal finding |
| Bronchial breath sounds | Louder, higher-pitched, hollow quality; heard over trachea normally; abnormal over lung periphery | Consolidation (pneumonia), lung tissue overlying large airway |
| Diminished or absent breath sounds | Reduced air entry to region of lung | Pleural effusion, pneumothorax, severe hyperinflation, mucus plugging, obesity |
| Polyphonic wheeze | Multiple musical pitches, primarily expiratory, widespread | Asthma, chronic obstructive pulmonary disease, bronchitis |
| Monophonic wheeze | Single fixed pitch, localized | Focal airway obstruction: tumor, foreign body, mucus plug |
| Stridor | High-pitched, monophonic, primarily inspiratory, heard over neck/upper chest | Upper airway obstruction: laryngeal edema, foreign body, tumor, vocal cord dysfunction |
| Fine crackles (rales) | High-pitched, brief, discontinuous sounds; like Velcro separating; end-inspiratory | Interstitial lung disease (bibasilar), early pulmonary edema, atelectasis |
| Coarse crackles | Lower-pitched, longer duration, early inspiratory; may clear with cough | Bronchiectasis, pneumonia, pulmonary edema, secretions in large airways |
| Pleural friction rub | Creaking, grating sound; heard in both phases; may vary with breathing but not with heartbeat | Pleuritis (infection, pulmonary embolism, malignancy, autoimmune) |
Cardiovascular Examination
| Finding | How to Assess | Clinical Significance |
|---|---|---|
| Jugular venous pressure elevation | Patient at 45 degrees; measure height of venous pulsation above sternal angle | Greater than 4 cm suggests right heart failure, volume overload, pulmonary hypertension, tamponade, constrictive pericarditis |
| Displaced apex beat | Palpate in left lateral decubitus position; normally at 5th intercostal space, midclavicular line | Lateral displacement suggests cardiomegaly (dilated cardiomyopathy, severe valvular disease) |
| Right ventricular heave | Palpable lift at left sternal border | Right ventricular hypertrophy (pulmonary hypertension, severe lung disease) |
| Third heart sound (S3) | Low-pitched sound in early diastole; best heard with bell at apex in left lateral position | Volume overload, systolic heart failure (highly specific when present in appropriate context) |
| Fourth heart sound (S4) | Low-pitched sound just before S1; best heard with bell at apex | Decreased ventricular compliance (hypertension, hypertrophic cardiomyopathy, ischemia) |
| Murmurs | Characterize by timing, location, radiation, intensity, and response to maneuvers | Aortic stenosis (crescendo-decrescendo systolic, radiates to carotids); mitral regurgitation (holosystolic, radiates to axilla); consider in any dyspneic patient |
| Peripheral edema | Press over tibial surface or sacrum for 5 seconds; grade by depth and extent | Right heart failure, venous insufficiency, hypoalbuminemia; sacral edema in bedridden patients |
Abdominal Examination
- Hepatomegaly: Pulsatile liver suggests tricuspid regurgitation; tender hepatomegaly in acute right heart failure
- Hepatojugular reflux: Sustained jugular venous pressure elevation with firm pressure over right upper quadrant suggests heart failure
- Ascites: Shifting dullness, fluid wave; may cause diaphragmatic splinting and dyspnea; consider hepatopulmonary syndrome if liver disease present
- Obesity: Central obesity restricts diaphragm movement; measure waist circumference
Extremities
Upper Extremities
- Clubbing: Loss of nail bed angle; associated with lung cancer, interstitial lung disease, bronchiectasis, cyanotic heart disease, endocarditis
- Peripheral cyanosis: Bluish discoloration of fingers; suggests poor perfusion or severe hypoxemia
- Nicotine staining: Indicates current smoking
- Asterixis: Flapping tremor with wrists extended; suggests carbon dioxide retention (hypercapnic respiratory failure)
Lower Extremities
- Peripheral edema: Bilateral suggests heart failure or venous insufficiency; unilateral raises concern for deep vein thrombosis
- Calf tenderness or swelling: Deep vein thrombosis (consider pulmonary embolism)
- Skin changes: Venous stasis changes, ulceration
- Muscle wasting: Severe chronic obstructive pulmonary disease, cachexia, deconditioning
Expected Findings by Etiology
| Condition | General and Vital Signs | Cardiopulmonary | Other Findings |
|---|---|---|---|
| Heart Failure | Tachycardia, possibly hypoxemia, often normal respiratory rate at rest | Elevated jugular venous pressure, displaced apex, S3 gallop, bibasilar crackles (may be absent in chronic disease) | Peripheral edema, hepatomegaly, hepatojugular reflux |
| Chronic Obstructive Pulmonary Disease | Tachypnea, pursed-lip breathing, prolonged expiration, may be hypoxemic | Barrel chest, diminished breath sounds, expiratory wheeze, hyperresonance | Cachexia in advanced disease, nicotine staining, asterixis if hypercapnic |
| Asthma Exacerbation | Tachypnea, tachycardia, pulsus paradoxus if severe, hypoxemia variable | Expiratory wheeze (silent chest is ominous), prolonged expiration, accessory muscle use | May have allergic features (rhinitis, eczema) |
| Pulmonary Embolism | Tachycardia (most common finding), tachypnea, hypoxemia variable, may be hypotensive | Often normal examination; may have pleural rub, loud P2 | Unilateral leg swelling or tenderness; low-grade fever possible |
| Pneumonia | Fever, tachycardia, tachypnea, hypoxemia | Bronchial breath sounds, crackles, dullness to percussion, egophony over consolidation | Signs of sepsis if severe (hypotension, confusion) |
| Pleural Effusion | Variable depending on size and underlying cause | Diminished breath sounds, dullness to percussion, reduced fremitus, tracheal deviation if large | Depends on cause (signs of malignancy, heart failure, infection) |
| Pneumothorax | Tachypnea, tachycardia, hypotension if tension | Diminished breath sounds, hyperresonance, tracheal deviation away if tension | Subcutaneous emphysema possible; tall, thin body habitus is risk factor for spontaneous pneumothorax |
| Interstitial Lung Disease | Tachypnea, hypoxemia (especially with exertion) | Fine bibasilar crackles (“Velcro” crackles), may be normal early | Clubbing; signs of connective tissue disease (skin changes, joint abnormalities) |
| Anemia | Tachycardia, normal oxygen saturation, pallor | Flow murmur (systolic) if severe; hyperdynamic precordium | Conjunctival and palmar pallor; signs related to cause (jaundice in hemolysis, koilonychia in iron deficiency) |
Important Teaching Point
Normal examination is common! Several important causes of dyspnea frequently present with entirely normal or near-normal physical examination findings. These include:
- Pulmonary embolism — The examination is often unremarkable; tachycardia may be the only finding
- Early interstitial lung disease — Crackles may not develop until disease is moderately advanced
- Heart failure with preserved ejection fraction — May have minimal signs at rest
- Anemia — Mild to moderate anemia often has no specific findings
- Deconditioning and obesity — Examination may be normal other than body habitus
- Anxiety and panic disorder — Physical examination is typically normal
A normal examination does not exclude significant pathology. The history remains paramount, and investigations are essential to reach a diagnosis.
Practical Tip: Bedside Exercise Testing
If the patient reports exertional dyspnea but appears comfortable at rest with a normal examination, consider bedside exercise testing. Have the patient walk in the hallway or climb stairs while monitoring oxygen saturation. Desaturation with exertion (drop of 4% or more or to less than 90%) suggests significant cardiopulmonary disease even when resting values are normal. This simple test can reveal interstitial lung disease, pulmonary vascular disease, or cardiac limitation that would otherwise be missed.
5. Differential Diagnosis
Systematic approach organized by probability, duration, and clinical features
Acute Dyspnea (Onset: Minutes to Hours)
Acute dyspnea requires rapid assessment to identify life-threatening conditions. The differential is guided by the clinical context and associated symptoms.
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Acute exacerbation of chronic obstructive pulmonary disease | Known chronic obstructive pulmonary disease, increased cough and sputum, wheeze, preceding upper respiratory infection | Altered mental status, severe hypoxemia, hypercapnia, accessory muscle use |
| Acute asthma exacerbation | Known asthma or atopy, wheeze, chest tightness, trigger exposure, nocturnal symptoms | Silent chest, inability to speak, peak expiratory flow less than 25% predicted, cyanosis | |
| Acute heart failure or pulmonary edema | Known cardiac disease, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, recent dietary indiscretion or medication non-adherence | Hypotension, severe hypoxemia, respiratory failure, cardiogenic shock | |
| Pneumonia | Fever, productive cough, pleuritic chest pain, recent upper respiratory symptoms | Sepsis, multilobar involvement, severe hypoxemia, confusion | |
| LESS COMMON (approximately 20%) | Pulmonary embolism | Sudden onset, pleuritic chest pain, risk factors (immobility, surgery, malignancy, oral contraceptives), unilateral leg swelling | Hypotension, syncope, massive embolism with right heart strain |
| Pneumothorax | Sudden onset, pleuritic pain, tall thin body habitus, known lung disease, recent procedure | Tension pneumothorax: hypotension, tracheal deviation, severe distress | |
| Acute coronary syndrome | Chest pain or pressure, diaphoresis, nausea, risk factors for coronary disease; dyspnea may be anginal equivalent | ST elevation, hemodynamic instability, arrhythmia | |
| UNCOMMON BUT SERIOUS (approximately 10%) | Cardiac tamponade | Known pericardial disease or malignancy, muffled heart sounds, elevated jugular venous pressure, pulsus paradoxus | Hypotension, Beck’s triad, electrical alternans on ECG |
| Anaphylaxis | Allergen exposure, urticaria, angioedema, stridor, wheeze, hypotension | Airway compromise, cardiovascular collapse | |
| Acute respiratory distress syndrome | Severe illness, sepsis, trauma, aspiration; bilateral infiltrates, refractory hypoxemia | Rapid progression, mechanical ventilation requirement | |
| Foreign body aspiration | Sudden onset during eating, choking episode, unilateral wheeze, stridor | Complete obstruction, severe hypoxemia |
Chronic Dyspnea (Duration: Greater than 4 to 8 Weeks)
Step-by-Step Approach to Chronic Dyspnea:
- Step 1: Rule out obvious causes — Is there known cardiac or pulmonary disease? Is the patient a smoker? Is there significant obesity? Are there abnormal findings on chest radiograph or ECG?
- Step 2: Consider the “Big Four” causes — Asthma (including cough-variant), chronic obstructive pulmonary disease, heart failure (including heart failure with preserved ejection fraction), and interstitial lung disease account for the vast majority of cases
- Step 3: Investigate for less common causes if initial workup is negative — Consider pulmonary hypertension, anemia, thyroid disease, neuromuscular disease, and deconditioning
- Step 4: Recognize that multiple causes often coexist — Particularly in elderly patients, two or three contributing conditions may be present simultaneously
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Chronic obstructive pulmonary disease | 25-30% of chronic dyspnea | Smoking history (typically greater than 10 pack-years), productive cough, progressive exertional limitation, spirometry showing obstruction (FEV1/FVC less than 0.70) |
| Asthma | 20-25% | Episodic symptoms, triggers (allergens, exercise, cold air), nocturnal symptoms, personal or family history of atopy, variable airflow obstruction, bronchodilator reversibility | |
| Heart failure | 15-20% | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, history of hypertension, coronary disease, or valvular disease; elevated BNP or NT-proBNP | |
| Obesity and deconditioning | 10-15% | BMI greater than 30, sedentary lifestyle, symptoms only with exertion, normal cardiopulmonary testing, improvement with exercise training and weight loss | |
| LESS COMMON | Interstitial lung disease | 5-10% | Progressive exertional dyspnea, dry cough, bibasilar crackles, restrictive pattern on spirometry, ground-glass or reticular changes on CT |
| Pulmonary hypertension | 3-5% | Exertional dyspnea with near-syncope, loud P2, right ventricular heave, peripheral edema, elevated pulmonary artery pressure on echocardiogram | |
| Anemia | 3-5% | Fatigue, pallor, palpitations, exertional symptoms, low hemoglobin; symptoms typically manifest when hemoglobin less than 10 g/dL | |
| Anxiety and panic disorder | 5-10% | Episodic symptoms with panic features, hyperventilation, perioral tingling, normal cardiopulmonary evaluation; often coexists with organic disease | |
| UNCOMMON | Chronic thromboembolic pulmonary hypertension | Less than 2% | History of pulmonary embolism (may be unrecognized), progressive exertional dyspnea, signs of pulmonary hypertension, ventilation-perfusion mismatch |
| Neuromuscular disease | Less than 2% | Orthopnea (early sign), weakness, reduced maximal inspiratory and expiratory pressures, restrictive pattern, hypercapnia in advanced disease | |
| Thyroid disease | Less than 2% | Hyperthyroidism: palpitations, weight loss, tremor; Hypothyroidism: fatigue, weight gain, pleural effusion; goiter may cause tracheal compression | |
| Pleural disease | Less than 2% | Prior pleurisy, recurrent effusions, trapped lung, pleural thickening on imaging |
Anatomical Approach to Dyspnea
Organizing the differential by anatomical location helps ensure comprehensive consideration of all possible causes.
Upper Airway
Laryngeal edema or tumor
Vocal cord dysfunction
Tracheal stenosis
Goiter with tracheal compression
Obstructive sleep apnea
Foreign body
Lower Airways and Lung Parenchyma
Asthma
Chronic obstructive pulmonary disease
Bronchiectasis
Interstitial lung disease
Pneumonia
Lung malignancy
Pulmonary Vasculature
Pulmonary embolism
Pulmonary arterial hypertension
Chronic thromboembolic pulmonary hypertension
Pulmonary veno-occlusive disease
Arteriovenous malformations
Cardiac and Extrapulmonary
Heart failure (systolic and diastolic)
Valvular heart disease
Coronary artery disease
Pericardial disease
Anemia
Neuromuscular disease
Chest wall disorders
Obesity and deconditioning
Drug-Induced Dyspnea
Medications can cause dyspnea through multiple mechanisms. Always review the medication list carefully in any patient with unexplained dyspnea.
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-blockers | Bronchospasm (especially non-selective agents); negative inotropy worsening heart failure; reduced exercise capacity | Wheeze, reduced exercise tolerance; more common in patients with reactive airways | Days to 1-2 weeks |
| Amiodarone | Direct pulmonary toxicity causing interstitial pneumonitis and fibrosis | Insidious onset, dry cough, progressive dyspnea; may occur months to years after starting; ground-glass opacities on CT | Weeks to months; may be irreversible if fibrosis established |
| Methotrexate | Hypersensitivity pneumonitis or direct pulmonary toxicity | Subacute onset, fever, dry cough, dyspnea; can occur at any dose; eosinophilia possible | Weeks with corticosteroid treatment |
| Nitrofurantoin | Acute hypersensitivity reaction or chronic pulmonary fibrosis | Acute form: fever, cough, dyspnea within days to weeks; Chronic form: insidious fibrosis with long-term use | Acute: days to weeks; Chronic: may be irreversible |
| Bleomycin | Dose-dependent pulmonary fibrosis; oxygen enhances toxicity | Progressive dyspnea, dry cough, bibasilar crackles; risk increases with cumulative dose greater than 400 units | May be irreversible; can progress after stopping |
| Non-steroidal anti-inflammatory drugs | Fluid retention worsening heart failure; aspirin-exacerbated respiratory disease (bronchospasm) | Worsening edema and dyspnea in heart failure; acute bronchospasm and rhinitis in aspirin-sensitive asthma | Days to weeks for fluid retention; hours for bronchospasm |
| Checkpoint inhibitors (immunotherapy) | Immune-mediated pneumonitis | New dyspnea, cough, fever during immunotherapy; ground-glass or organizing pneumonia pattern | Weeks to months with corticosteroids; may require prolonged immunosuppression |
| Opioids | Respiratory center depression; reduced respiratory drive | Reduced respiratory rate, hypercapnia, somnolence; particularly concerning in opioid-naive patients or with dose escalation | Hours (with naloxone if severe); longer with long-acting formulations |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Sudden onset at rest with pleuritic chest pain | Pulmonary embolism or pneumothorax | Chest radiograph, D-dimer or CT pulmonary angiography based on pretest probability |
| Orthopnea and paroxysmal nocturnal dyspnea | Heart failure | BNP or NT-proBNP, echocardiogram, chest radiograph |
| Episodic wheeze with symptom-free intervals | Asthma | Spirometry with bronchodilator reversibility testing |
| Smoker with progressive exertional dyspnea and chronic cough | Chronic obstructive pulmonary disease | Spirometry (FEV1/FVC less than 0.70 confirms diagnosis) |
| Bibasilar crackles with progressive dyspnea | Interstitial lung disease or heart failure | BNP, high-resolution CT chest, pulmonary function tests |
| Exertional dyspnea with near-syncope | Pulmonary hypertension or severe aortic stenosis | Echocardiogram with estimation of pulmonary artery pressure |
| Dyspnea with fatigue and pallor | Anemia | Complete blood count |
| Unilateral leg swelling with dyspnea | Deep vein thrombosis with pulmonary embolism | Leg ultrasound, D-dimer, CT pulmonary angiography |
| Episodic dyspnea with panic symptoms and perioral tingling | Anxiety or panic disorder (but exclude organic causes first) | Complete cardiopulmonary evaluation to exclude organic disease before attributing to anxiety |
| Dyspnea worse when supine, relieved by sitting | Heart failure, bilateral diaphragm weakness, or severe chronic obstructive pulmonary disease | Echocardiogram; consider diaphragm ultrasound or sniff test if neuromuscular disease suspected |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of dyspnea should be systematic and guided by the clinical presentation. In acute dyspnea, investigations focus on identifying or excluding life-threatening conditions. In chronic dyspnea, a stepwise approach starting with basic tests and progressing to more specialized investigations based on results is most efficient.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Chest radiograph | Detect parenchymal disease, effusions, cardiomegaly, pneumothorax | Infiltrates, effusion, cardiomegaly, hyperinflation, interstitial markings, masses, pneumothorax | Normal result does not exclude pulmonary embolism, asthma, early interstitial lung disease, or heart failure with preserved ejection fraction |
| Electrocardiogram | Detect arrhythmia, ischemia, chamber enlargement, pericardial disease | Atrial fibrillation, ST changes, left ventricular hypertrophy, right heart strain pattern (S1Q3T3), low voltage | Essential in acute dyspnea; may reveal unsuspected atrial fibrillation as cause of decompensation |
| Complete blood count | Detect anemia, polycythemia, infection | Hemoglobin less than 10 g/dL may contribute to dyspnea; leukocytosis suggests infection; eosinophilia in asthma or eosinophilic lung disease | Often overlooked but essential; mild anemia frequently contributes to symptoms |
| Basic metabolic panel | Assess renal function, electrolytes, identify metabolic acidosis | Elevated creatinine (fluid overload), low bicarbonate (metabolic acidosis driving hyperventilation), electrolyte abnormalities | Metabolic acidosis (from any cause) stimulates respiratory drive and causes dyspnea |
| B-type natriuretic peptide or NT-proBNP | Evaluate for heart failure | BNP greater than 100 pg/mL or NT-proBNP greater than 300 pg/mL suggests heart failure; higher thresholds in elderly and those with renal impairment | Excellent negative predictive value; normal level effectively rules out heart failure; obesity may lower levels |
| Pulse oximetry | Assess oxygenation | Saturation less than 94% on room air is abnormal; desaturation with exertion is significant even if resting saturation is normal | Normal saturation does not exclude significant disease; check with exertion if resting value is normal |
| Arterial blood gas (if indicated) | Assess gas exchange, acid-base status | Hypoxemia, hypercapnia, acidosis (respiratory or metabolic), elevated A-a gradient | Essential in acute respiratory distress; helps differentiate causes of hypoxemia; identifies hypercapnic respiratory failure |
Second-Line Investigations Based on Initial Findings
| Investigation | When to Order | Key Findings and Interpretation |
|---|---|---|
| Spirometry | All patients with chronic dyspnea; suspected asthma or chronic obstructive pulmonary disease | FEV1/FVC less than 0.70: obstructive pattern (chronic obstructive pulmonary disease, asthma); FVC reduced with normal ratio: restrictive pattern; bronchodilator response (greater than 12% and 200 mL improvement) suggests asthma |
| Echocardiogram | Suspected heart failure, valvular disease, pulmonary hypertension; elevated natriuretic peptides | Ejection fraction (reduced less than 40%, preserved greater than 50%); diastolic dysfunction; valvular abnormalities; estimated pulmonary artery systolic pressure; pericardial effusion |
| CT pulmonary angiography | Suspected pulmonary embolism based on clinical probability and D-dimer | Filling defects in pulmonary arteries; also evaluates for alternative diagnoses (pneumonia, effusion, mass) |
| D-dimer | Low to intermediate pretest probability for pulmonary embolism; use age-adjusted cutoff (age × 10 for patients over 50) | Negative result (less than 500 ng/mL or age-adjusted) effectively excludes pulmonary embolism in low-risk patients; not useful if high pretest probability |
| High-resolution CT chest | Suspected interstitial lung disease; unexplained restrictive pattern; abnormal chest radiograph with unclear diagnosis | Ground-glass opacities, reticular changes, honeycombing, traction bronchiectasis; pattern and distribution help diagnose specific interstitial lung diseases |
| Thyroid function tests | Unexplained dyspnea, especially with palpitations, weight changes, or goiter | Hyperthyroidism causes increased oxygen demand and cardiac output; hypothyroidism may cause pleural effusion, muscle weakness |
Targeted Investigations by Suspected Etiology
If Suspecting Asthma
First-Line Tests
- Spirometry with bronchodilator: FEV1 improvement of greater than 12% AND greater than 200 mL after bronchodilator supports diagnosis
- Peak expiratory flow variability: Greater than 20% diurnal variation over 2 weeks is consistent with asthma
Second-Line Tests
- Fractional exhaled nitric oxide: Greater than 50 ppb in adults suggests eosinophilic airway inflammation; useful when spirometry is normal
- Methacholine challenge: PC20 less than 4 mg/mL is positive; high sensitivity—negative test effectively rules out asthma
- Allergy testing: Skin prick or specific IgE to identify triggers
If Suspecting Heart Failure
First-Line Tests
- BNP or NT-proBNP: BNP less than 100 pg/mL or NT-proBNP less than 300 pg/mL makes heart failure unlikely
- Echocardiogram: Assess systolic function, diastolic function, valvular disease, and pulmonary pressures
- Chest radiograph: Cardiomegaly, pulmonary venous congestion, pleural effusions
Second-Line Tests
- Stress testing: If coronary artery disease suspected as underlying cause
- Cardiac MRI: For cardiomyopathy evaluation, myocardial viability, infiltrative disease
- Right heart catheterization: If pulmonary hypertension suspected or for hemodynamic assessment before advanced therapies
If Suspecting Pulmonary Embolism
Risk Stratification
- Wells score or Geneva score: Determine pretest probability (low, intermediate, high)
- PERC rule: If all 8 criteria negative and low clinical suspicion, pulmonary embolism effectively excluded without testing
Diagnostic Testing
- D-dimer: Use age-adjusted cutoff; if negative with low-intermediate probability, pulmonary embolism excluded
- CT pulmonary angiography: Gold standard for diagnosis; proceed directly if high probability or positive D-dimer
- Ventilation-perfusion scan: Alternative if contraindication to CT contrast; also useful in chronic thromboembolic pulmonary hypertension workup
If Suspecting Interstitial Lung Disease
First-Line Tests
- High-resolution CT chest: Essential for diagnosis and pattern recognition; inspiratory and expiratory images
- Pulmonary function tests: Restrictive pattern (reduced FVC with normal or elevated FEV1/FVC ratio); reduced diffusing capacity for carbon monoxide (DLCO)
Second-Line Tests
- Autoimmune serologies: ANA, rheumatoid factor, anti-CCP, myositis antibodies if connective tissue disease suspected
- Hypersensitivity pneumonitis panel: If exposure history suggests
- Bronchoscopy with bronchoalveolar lavage: Cell differential may help narrow diagnosis
- Surgical lung biopsy: If diagnosis unclear and would change management
Complete Pulmonary Function Testing
Components and Interpretation
Full pulmonary function tests provide comprehensive assessment of lung mechanics and gas exchange:
- Spirometry: FEV1, FVC, FEV1/FVC ratio — identifies obstructive or restrictive patterns
- Lung volumes: Total lung capacity (TLC), residual volume — confirms restriction (reduced TLC) or hyperinflation (elevated TLC and residual volume)
- Diffusing capacity (DLCO): Reduced in interstitial lung disease, emphysema, pulmonary vascular disease; normal in asthma and pure airway disease
- Maximal inspiratory and expiratory pressures: Reduced in neuromuscular disease
| Pattern | Spirometry | Lung Volumes | DLCO | Suggests |
|---|---|---|---|---|
| Obstructive | FEV1/FVC less than 0.70; reduced FEV1 | Normal or increased TLC; increased residual volume | Normal (asthma) or reduced (emphysema) | Asthma, chronic obstructive pulmonary disease, bronchiectasis |
| Restrictive | FEV1/FVC normal or increased; reduced FVC | Reduced TLC | Usually reduced | Interstitial lung disease, chest wall disease, neuromuscular disease |
| Mixed | FEV1/FVC less than 0.70; reduced FVC | Reduced TLC | Usually reduced | Combined chronic obstructive pulmonary disease and interstitial lung disease; severe chronic obstructive pulmonary disease with air trapping |
| Isolated low DLCO | Normal | Normal | Reduced | Pulmonary vascular disease, early interstitial lung disease, anemia |
Cardiopulmonary Exercise Testing
When Initial Workup Is Non-Diagnostic
Cardiopulmonary exercise testing (CPET) is invaluable when the cause of dyspnea remains unclear after basic testing. It simultaneously assesses cardiac, pulmonary, and metabolic responses to exercise and can identify:
- Cardiac limitation: Early anaerobic threshold, abnormal oxygen pulse, ischemic ECG changes
- Pulmonary limitation: Ventilatory limitation (reaching maximal voluntary ventilation), exercise-induced hypoxemia, increased dead space ventilation
- Deconditioning: Low peak oxygen consumption with normal cardiac and pulmonary responses; early anaerobic threshold with rapid recovery
- Pulmonary vascular limitation: Abnormal ventilatory efficiency (elevated VE/VCO2 slope), exercise-induced hypoxemia, low peak oxygen consumption
CPET is particularly useful in patients with multiple potential contributing factors (such as obesity plus mild chronic obstructive pulmonary disease) to determine the predominant cause of limitation.
Empiric Treatment Trials as Diagnostic Tools
When Objective Testing Is Inconclusive
In some cases, particularly when asthma or gastroesophageal reflux is suspected but testing is non-diagnostic, empiric treatment trials can serve as diagnostic tools:
- Inhaled corticosteroid trial (4-8 weeks): Improvement supports diagnosis of asthma or eosinophilic bronchitis; continue if effective
- Proton pump inhibitor trial (8-12 weeks): If gastroesophageal reflux-related dyspnea suspected; must use twice-daily dosing for adequate trial
- Diuretic trial: In patients with borderline heart failure findings; improvement with diuresis supports cardiac contribution
Document baseline symptoms quantitatively before starting treatment trial to objectively assess response.
Investigation Algorithm Summary
Stepwise Approach to Chronic Dyspnea Investigation:
- All patients: Chest radiograph, ECG, complete blood count, basic metabolic panel, BNP or NT-proBNP, pulse oximetry
- If cardiac cause suspected: Echocardiogram; stress testing if ischemia suspected
- If pulmonary cause suspected: Spirometry with bronchodilator; high-resolution CT if interstitial disease suspected
- If pulmonary embolism suspected: D-dimer (if low-intermediate probability) → CT pulmonary angiography if positive or high probability
- If diagnosis remains unclear: Complete pulmonary function tests with DLCO; consider cardiopulmonary exercise testing
- If still unclear after comprehensive testing: Consider empiric treatment trials; reassess for anxiety or psychogenic dyspnea (diagnosis of exclusion)
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
The first priority in any patient with dyspnea is to determine the urgency of the situation. This guides the pace of evaluation and immediate interventions.
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Respiratory distress with hypoxemia (SpO2 less than 90%), altered mental status, or hemodynamic instability | EMERGENT | Supplemental oxygen, IV access, continuous monitoring, prepare for intubation if needed, emergent evaluation (ECG, portable chest radiograph, arterial blood gas) |
| Stridor, severe wheeze with inability to speak, or signs of anaphylaxis | EMERGENT | Airway management priority; epinephrine if anaphylaxis; nebulized epinephrine for stridor; prepare for surgical airway if upper obstruction |
| Suspected tension pneumothorax (hypotension, tracheal deviation, absent breath sounds) | EMERGENT | Immediate needle decompression followed by chest tube; do not wait for chest radiograph |
| Acute dyspnea with chest pain, risk factors for pulmonary embolism or acute coronary syndrome | URGENT | ECG, troponin, D-dimer or CT pulmonary angiography based on probability; anticoagulation if high suspicion for pulmonary embolism pending imaging |
| New or worsening dyspnea in patient with known heart failure or chronic obstructive pulmonary disease | URGENT | Assess for exacerbation triggers; chest radiograph, ECG, BNP; initiate treatment for presumed exacerbation while completing workup |
| Fever with dyspnea suggesting pneumonia | URGENT | Chest radiograph, blood cultures if severe; early antibiotics after obtaining cultures; assess severity with CURB-65 or PSI |
| Chronic progressive dyspnea, stable vital signs, no red flags | ROUTINE | Systematic outpatient workup; baseline investigations followed by targeted testing based on clinical suspicion |
| Exertional dyspnea with normal examination and stable symptoms | ROUTINE | Outpatient evaluation with spirometry, echocardiogram, and further testing as indicated; ensure appropriate follow-up |
Step 2: Classify by Duration and Onset
Acute (Minutes to Hours)
Proceed to Algorithm A
Focus on life-threatening conditions: pulmonary embolism, pneumothorax, acute coronary syndrome, anaphylaxis, acute heart failure, severe asthma exacerbation
Subacute (Days to Weeks)
Proceed to Algorithm B
Consider: pneumonia, pleural effusion, heart failure exacerbation, progressive anemia, subacute pulmonary embolism, malignancy
Chronic (Greater than 4-8 Weeks)
Proceed to Algorithm C
Systematic workup for the “Big Four”: chronic obstructive pulmonary disease, asthma, heart failure, interstitial lung disease; also consider obesity, deconditioning, pulmonary hypertension
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sudden onset, pleuritic chest pain, unilateral leg swelling, recent immobility or surgery | Pulmonary embolism | Calculate Wells score; D-dimer if low-intermediate probability; CT pulmonary angiography if high probability or positive D-dimer; anticoagulate if high suspicion |
| Sudden onset, pleuritic pain, absent breath sounds unilaterally, hyperresonance | Pneumothorax | Chest radiograph (upright expiratory if stable); chest tube if large or symptomatic; needle decompression if tension physiology |
| Known asthma, wheeze, chest tightness, trigger exposure | Acute asthma exacerbation | Peak flow, oxygen; nebulized bronchodilators; systemic corticosteroids; reassess response; ICU if severe |
| Known heart failure, orthopnea, peripheral edema, recent dietary or medication non-adherence | Acute decompensated heart failure | Chest radiograph, BNP, ECG; IV diuretics; non-invasive ventilation if severe; identify precipitant (ischemia, arrhythmia, infection) |
| Fever, productive cough, focal crackles or bronchial breathing | Community-acquired pneumonia | Chest radiograph; severity assessment (CURB-65); blood cultures if severe; early appropriate antibiotics |
| Chest pain with ECG changes, elevated troponin | Acute coronary syndrome | Serial ECGs, troponin; antiplatelet therapy; cardiology consultation; consider coronary angiography |
| Allergen exposure, urticaria, angioedema, stridor, hypotension | Anaphylaxis | Intramuscular epinephrine immediately; IV fluids; airway management; antihistamines and corticosteroids as adjuncts |
Algorithm B: Subacute Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Progressive dyspnea over days, fever, cough with purulent sputum | Pneumonia (possibly with parapneumonic effusion) | Chest radiograph; if effusion present, consider thoracentesis; appropriate antibiotics based on severity and risk factors |
| Gradually worsening dyspnea, dullness to percussion at lung base, diminished breath sounds | Pleural effusion | Chest radiograph or ultrasound; thoracentesis for diagnosis (Light’s criteria) and symptom relief; treat underlying cause |
| Progressive fatigue and dyspnea, pallor, possible gastrointestinal symptoms | Anemia (acute blood loss or hemolysis) | Complete blood count, reticulocyte count; identify source of bleeding or hemolysis; transfusion if symptomatic or hemoglobin less than 7 g/dL |
| Known malignancy, progressive dyspnea, possible weight loss | Malignant pleural effusion, lymphangitic carcinomatosis, or pericardial effusion | CT chest; thoracentesis with cytology; echocardiogram if pericardial effusion suspected; oncology consultation |
| Worsening exertional dyspnea following viral illness | Post-viral myocarditis or reactive airways | ECG, troponin, BNP, echocardiogram; spirometry if airway symptoms; cardiac MRI if myocarditis suspected |
Algorithm C: Chronic Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Smoker (greater than 10 pack-years), chronic productive cough, progressive exertional dyspnea | Chronic obstructive pulmonary disease | Spirometry (FEV1/FVC less than 0.70 confirms diagnosis); assess severity by FEV1; chest radiograph; initiate bronchodilators |
| Episodic wheeze and chest tightness, symptom-free intervals, triggers, nocturnal symptoms | Asthma | Spirometry with bronchodilator reversibility; peak flow diary; fractional exhaled nitric oxide if available; initiate inhaled corticosteroid |
| Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, history of hypertension or coronary disease | Heart failure | BNP or NT-proBNP, echocardiogram; if confirmed, classify as reduced or preserved ejection fraction; initiate guideline-directed medical therapy |
| Progressive exertional dyspnea, dry cough, bibasilar crackles, occupational or connective tissue disease exposure | Interstitial lung disease | High-resolution CT chest; complete pulmonary function tests with DLCO; autoimmune serologies; pulmonology referral |
| Exertional dyspnea with near-syncope, loud P2, right ventricular heave | Pulmonary hypertension | Echocardiogram for estimated pulmonary artery pressure; if elevated, refer for right heart catheterization; ventilation-perfusion scan to exclude chronic thromboembolic disease |
| Obese patient, symptoms only with exertion, normal cardiopulmonary testing | Obesity and deconditioning | Confirm with cardiopulmonary exercise testing if diagnosis uncertain; weight loss and exercise rehabilitation; consider obstructive sleep apnea evaluation |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Oxygen saturation is less than 90% | Apply supplemental oxygen to target SpO2 92-96% (88-92% if chronic obstructive pulmonary disease with hypercapnic risk) | Arterial blood gas to assess severity; identify and treat underlying cause; consider non-invasive ventilation if tiring or hypercapnic |
| Patient is too breathless to speak in sentences | Assume severe respiratory distress; apply oxygen, establish IV access, continuous monitoring | Prepare for possible intubation; treat empirically for most likely cause (bronchodilators for wheeze, diuretics for pulmonary edema) |
| D-dimer is positive but CT pulmonary angiography is negative | Pulmonary embolism is effectively excluded; do not anticoagulate | Consider alternative diagnoses; D-dimer is nonspecific (elevated in infection, malignancy, inflammation); pursue other causes of dyspnea |
| BNP is borderline elevated (100-400 pg/mL) | Heart failure is possible but not certain; consider other causes of elevation (renal failure, pulmonary hypertension, obesity) | Obtain echocardiogram to assess cardiac structure and function; BNP should be interpreted in clinical context |
| Chest radiograph and spirometry are normal but patient has significant dyspnea | Do not dismiss symptoms; normal basic tests do not exclude significant pathology | Complete pulmonary function tests with DLCO; echocardiogram; consider cardiopulmonary exercise testing; evaluate for pulmonary hypertension, interstitial lung disease, anemia |
| Patient is wheezing but has no history of asthma or chronic obstructive pulmonary disease | Treat bronchospasm with bronchodilators while determining cause | Consider heart failure (“cardiac asthma”), pulmonary embolism, anaphylaxis, foreign body, vocal cord dysfunction; do not assume asthma without confirmation |
| Suspected pulmonary embolism but CT contrast is contraindicated | Consider ventilation-perfusion scan as alternative imaging | If high clinical suspicion and imaging inconclusive, consider empiric anticoagulation with close follow-up; lower extremity ultrasound may support diagnosis if deep vein thrombosis found |
| Patient has dyspnea but all objective testing is normal | Reconsider diagnosis; review history for anxiety, panic disorder, or psychogenic dyspnea; ensure deconditioning has been addressed | Cardiopulmonary exercise testing to objectively assess exercise limitation; consider empiric treatment trial for possible asthma; psychiatric evaluation if appropriate; do not abandon patient |
Addressing Multiple Contributing Causes
Dyspnea Is Often Multifactorial
Particularly in elderly patients or those with multiple comorbidities, dyspnea frequently results from the combination of several contributing factors. For example:
- Mild chronic obstructive pulmonary disease + mild heart failure + obesity + deconditioning
- Interstitial lung disease + anemia + anxiety
- Heart failure with preserved ejection fraction + pulmonary hypertension + obesity
When multiple contributing factors are identified, address each one. Improvement may require treating all contributing conditions. Do not stop investigating after finding one abnormality if symptoms seem out of proportion to that single finding.
Troubleshooting Refractory Dyspnea
Ask These Questions When Dyspnea Persists Despite Treatment
- Is the diagnosis correct? — Reconsider the differential; additional testing may be needed
- Are there multiple contributing causes? — One treated condition may not explain all symptoms
- Is treatment adequate? — Subtherapeutic dosing, poor inhaler technique, medication non-adherence
- Has a complication developed? — New arrhythmia, infection, pulmonary hypertension in chronic obstructive pulmonary disease
- Is deconditioning a factor? — Even with optimal medical therapy, patients need pulmonary or cardiac rehabilitation
- Is anxiety amplifying symptoms? — Common comorbidity that worsens dyspnea perception; treat both the organic cause and anxiety
- Has a new condition developed? — Patients with one cause of dyspnea can develop another (for example, lung cancer in chronic obstructive pulmonary disease patient)
When to Refer to a Specialist
| Refer To | When |
|---|---|
| Pulmonology | Suspected interstitial lung disease; unexplained pulmonary function abnormalities; severe or refractory asthma or chronic obstructive pulmonary disease; need for bronchoscopy; pulmonary hypertension evaluation |
| Cardiology | New heart failure diagnosis for optimization; valvular heart disease; suspected pulmonary hypertension; unexplained cardiomegaly; consideration of advanced therapies |
| Thoracic surgery | Recurrent pneumothorax; large or symptomatic pleural effusion requiring intervention; lung biopsy for diagnosis; consideration of lung volume reduction surgery |
| Palliative care | Refractory dyspnea in advanced disease; focus on symptom management and quality of life when disease-modifying treatments are limited |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Big Four” dominate chronic dyspnea: Chronic obstructive pulmonary disease, asthma, heart failure, and interstitial lung disease account for the vast majority of chronic dyspnea in patients with normal or near-normal chest radiographs. A systematic approach to these conditions will yield a diagnosis in most cases.
Normal oxygen saturation does not exclude serious disease: Pulmonary embolism frequently presents with normal oxygen saturation. Interstitial lung disease may have normal resting saturation with desaturation only on exertion. Always check saturation with ambulation if the resting value is normal and symptoms are significant.
BNP has excellent negative predictive value: A BNP less than 100 pg/mL or NT-proBNP less than 300 pg/mL makes heart failure very unlikely. This is one of the most useful tests for ruling out cardiac causes of dyspnea. However, remember that obesity can lower natriuretic peptide levels, and renal failure can elevate them.
Dyspnea quality provides diagnostic clues: “Air hunger” suggests chemoreceptor stimulation (hypoxemia, hypercapnia, acidosis); “effort” suggests mechanical loading; “chest tightness” is relatively specific for bronchoconstriction. Asking patients to describe the sensation can help narrow the differential.
Orthopnea and paroxysmal nocturnal dyspnea are highly specific for heart failure: When present, these symptoms strongly suggest heart failure even if other findings are subtle. Their absence makes heart failure less likely but does not exclude it, especially heart failure with preserved ejection fraction.
Consider pulmonary embolism in any unexplained dyspnea: Pulmonary embolism is a “great masquerader.” The classic triad of dyspnea, pleuritic chest pain, and hemoptysis is present in less than 20% of cases. Tachycardia may be the only clinical finding. Maintain a high index of suspicion, especially with sudden onset or risk factors.
Deconditioning is underdiagnosed and treatable: Many patients with chronic dyspnea have significant deconditioning as a contributing or primary factor. This is particularly common in patients with known cardiopulmonary disease who have become sedentary. Pulmonary and cardiac rehabilitation programs provide substantial benefit.
Multiple causes frequently coexist: Especially in elderly patients, dyspnea often results from the combination of several conditions, each contributing partially. Do not stop investigating after finding one abnormality if symptoms seem disproportionate to that single diagnosis.
Critical Pitfalls to Avoid
Attributing dyspnea to anxiety without thorough evaluation: Anxiety and panic disorder should be diagnoses of exclusion. Many serious conditions (pulmonary embolism, arrhythmia, pulmonary hypertension) can present with episodic symptoms that mimic panic. Complete a cardiopulmonary workup before concluding that dyspnea is psychogenic.
Assuming all wheeze is asthma: Wheeze can occur in heart failure (“cardiac asthma”), pulmonary embolism, foreign body aspiration, vocal cord dysfunction, and airway tumors. Do not empirically treat for asthma without considering the full differential, especially in patients without prior asthma diagnosis.
Missing pulmonary embolism due to normal examination and oxygen saturation: The physical examination is often normal in pulmonary embolism, and oxygen saturation may be preserved. Clinical suspicion based on risk factors and presentation is essential. Use validated scoring systems (Wells, Geneva) to guide testing.
Overlooking heart failure with preserved ejection fraction: Dyspnea, particularly exertional, with a normal ejection fraction on echocardiogram does not exclude heart failure. Heart failure with preserved ejection fraction requires evaluation of diastolic function, BNP, and often exercise testing to diagnose. This condition is common and frequently missed.
Failing to review the medication list: Drug-induced dyspnea is common and treatable. Amiodarone, methotrexate, nitrofurantoin, beta-blockers, and non-steroidal anti-inflammatory drugs can all cause or worsen dyspnea. Always review medications in any patient with unexplained symptoms.
Ignoring anemia as a contributing factor: Anemia is easily overlooked but frequently contributes to dyspnea. Even mild to moderate anemia (hemoglobin 8-11 g/dL) can cause significant exertional symptoms. Always check a complete blood count in the evaluation of dyspnea.
Using bronchodilator response alone to diagnose asthma: A positive bronchodilator response supports asthma but is not always present, and a negative response does not exclude it. Patients with well-controlled asthma may have normal spirometry. Methacholine challenge and fractional exhaled nitric oxide can help when spirometry is non-diagnostic.
Delaying evaluation of chronic dyspnea: Patients often adapt to chronic dyspnea and may not seek care until disease is advanced. Early detection of interstitial lung disease, pulmonary hypertension, or heart failure allows for earlier treatment and better outcomes. Take chronic dyspnea seriously even when patients minimize symptoms.
Key Takeaways
- Dyspnea is a subjective symptom arising from complex interactions between respiratory drive, mechanical response, and cortical perception. Understanding the underlying mechanism helps identify the cause and guide treatment.
- Classify dyspnea by duration (acute, subacute, chronic) and pattern (exertional, orthopnea, paroxysmal nocturnal dyspnea) to narrow the differential diagnosis efficiently.
- Red flags requiring urgent evaluation include sudden onset at rest, stridor, hemoptysis, chest pain, syncope, hypoxemia, and hemodynamic instability.
- The “BREATHE” mnemonic ensures comprehensive history taking: Begin with onset, Related symptoms, Exertion and Exacerbating factors, Alleviating factors, Timeline, History, and Effect on daily life.
- Physical examination should be systematic but recognize that many important causes of dyspnea (pulmonary embolism, early interstitial lung disease, heart failure with preserved ejection fraction) may have normal or near-normal examination findings.
- Baseline investigations for all patients with dyspnea include chest radiograph, ECG, complete blood count, basic metabolic panel, BNP or NT-proBNP, and pulse oximetry.
- Spirometry is essential for evaluating chronic dyspnea and distinguishes obstructive from restrictive patterns. Normal spirometry does not exclude asthma or interstitial lung disease.
- BNP and NT-proBNP have excellent negative predictive value for heart failure. A normal value effectively rules out heart failure in most clinical scenarios.
- Consider pulmonary embolism in any patient with unexplained acute or subacute dyspnea, especially with risk factors. Use validated clinical prediction rules to guide testing.
- Chronic dyspnea is often multifactorial, particularly in elderly patients. Identify and treat all contributing conditions for optimal symptom improvement.
- Deconditioning contributes to dyspnea in many patients with chronic cardiopulmonary disease. Pulmonary and cardiac rehabilitation should be part of the treatment plan.
- When basic testing is non-diagnostic, complete pulmonary function tests with diffusing capacity, echocardiography, and cardiopulmonary exercise testing can identify occult disease or clarify the primary limitation.
Quick Reference Algorithm
Systematic Approach to Dyspnea:
- Assess urgency: Identify red flags and life-threatening conditions requiring immediate intervention
- Classify by duration: Acute (minutes to hours), subacute (days to weeks), or chronic (greater than 4-8 weeks) to guide differential diagnosis
- Take a focused history: Use the “BREATHE” mnemonic; characterize onset, associated symptoms, exacerbating and alleviating factors, timeline, medical history, and functional impact
- Perform systematic examination: Vital signs, general inspection, head and neck, respiratory, cardiovascular, abdominal, and extremities; note that normal examination does not exclude serious disease
- Obtain baseline investigations: Chest radiograph, ECG, complete blood count, basic metabolic panel, BNP or NT-proBNP, pulse oximetry (with exertion if resting normal)
- Order targeted testing based on clinical suspicion: Spirometry for suspected airway disease; echocardiogram for suspected heart failure; CT pulmonary angiography for suspected pulmonary embolism; high-resolution CT for suspected interstitial lung disease
- Consider cardiopulmonary exercise testing: When diagnosis remains unclear or to determine the primary cause of limitation when multiple conditions coexist
- Treat all contributing factors: Recognize that dyspnea is often multifactorial; address deconditioning with rehabilitation; treat anxiety if present as a comorbidity
- Arrange appropriate follow-up: Reassess response to treatment; refer to specialists when indicated; do not abandon patients with unexplained symptoms